XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2
Discontinued development of drug candidates - Additional Information (Detail)
$ in Millions
Jun. 30, 2022
USD ($)
STOPS  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Non-cancellable purchase commitments $ 3.8
Antisense Oligonucleotide  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Non-cancellable purchase commitments $ 3.4